Common blood pressure drugs show positive link with breast cancer survival
Jun 3, 2011
Breast cancer survivors taking beta-blockers for blood pressure were shown to have a lower recurrence as well as longer survival, according to a new report from Reuters.
"We saw an association, now it's time to prove whether they are the cause. It's very promising, it's encouraging, but we still have to do the studies," Dr. Amal Melhem-Bertrandt, a researcher in one of the two studies, told the news source.
Melhem-Bertrandt works for the M.D. Anderson Cancer Center in Houston and studied about 1,400 women who were undergoing surgery and chemotherapy for breast cancer.
The study looked at the women three years after their surgeries, and found that those taking beta-blockers had an 87 percent rate of survival without cancer recurrence. Those not on the blood pressure medicine had a survival and no-recurrence rate of only 77 percent.
One in eight women in the U.S. are affected by breast cancer at some point in her lifetime, according to the American Cancer Society. More than 200,000 women were newly diagnosed with the illness in 2010, reports the ACS.